4/6/2020 CN110870402A - Prescription for treating pneumonia infected by novel coronavirus and application thereof - Google Patents

 Patents CN110870402

Prescription for treating pneumonia infected by novel coronavirus and application thereof

Abstract
CN110870402A
The invention relates to a traditional Chinese medicine composition, and particularly discloses a
China
prescription for treating pneumonia caused by novel coronavirus infection and application thereof.
The raw materials of the prescription comprise the following traditional Chinese medicine materials
in parts by weight: 9 parts of ephedra, 6 parts of honey-fried licorice root, 9 parts of almond, 15-30 Download PDF Find Prior Art Similar
parts of gypsum, 9 parts of cassia twig, 9 parts of rhizoma alismatis, 9 parts of grifola, 9 parts of
bighead atractylodes rhizome, 15 parts of poria cocos, 16 parts of radix bupleuri, 6 parts of Other languages: Chinese
scutellaria baicalensis, 9 parts of ginger processed pinellia tuber, 9 parts of ginger, 9 parts of aster, 9
Inventor: 葛又文
parts of os farae, 9 parts of blackberry lily, 6 parts of asarum, 12 parts of Chinese yam, 6 parts of
immature bitter orange, 6 parts of dried orange peel and 9 parts of wrinkled gianthyssop herb. The
invention combines the pneumonia symptom expression of the novel coronavirus (2019-nCoV) Worldwide applications
infection, optimizes and fuses the traditional Chinese medicine formula, and treats the pneumonia
2020 CN
together. From the prior treatment conditions of patients with con rmed diagnosis at different ages,
a plurality of provinces and a plurality of places, the curative effect is de nite, and the effective rate
of the treatment reaches 95.12 percent. Application CN202010081961.5A events

2020-02-06 Application led by 葛又文

2020-02-06 Priority to CN202010081961.5A

2020-03-06 Publication of CN110870402A

Info: Legal events, Similar documents, Priority and Related

Applications

External links: Espacenet, Global Dossier, Discuss

Claims (9) Hide Dependent

1. A prescription for treating pneumonia infected by novel coronavirus is characterized in that the raw materials comprise the following traditional Chinese medicine materials in
parts by weight:

8-10 parts of ephedra, 5-8 parts of honey-fried licorice root, 8-10 parts of almond, 15-30 parts of gypsum, 8-10 parts of cassia twig, 8-10 parts of rhizoma alismatis, 8-10 parts of
polyporus umbellatus, 8-10 parts of bighead atractylodes rhizome, 15 parts of poria cocos, 15-18 parts of radix bupleuri, 5-8 parts of scutellaria baicalensis, 8-10 parts of ginger
processed pinellia tuber, 8-10 parts of ginger, 8-10 parts of aster, 8-10 parts of os farfarae, 8-10 parts of blackberry lily, 5-8 parts of asarum, 10-14 parts of Chinese yam, 5-8
parts of immature bitter orange, 5-8 parts of dried orange peel and 8-10 parts of wrinkled gianthys.

2. The prescription according to claim 1, wherein the raw materials comprise the following Chinese medicinal materials in parts by weight:

9 parts of ephedra, 6 parts of honey-fried licorice root, 9 parts of almond, 15-30 parts of gypsum, 9 parts of cassia twig, 9 parts of rhizoma alismatis, 9 parts of grifola, 9
parts of bighead atractylodes rhizome, 15 parts of poria cocos, 16 parts of radix bupleuri, 6 parts of scutellaria baicalensis, 9 parts of ginger processed pinellia tuber, 9
parts of ginger, 9 parts of aster, 9 parts of os farae, 9 parts of blackberry lily, 6 parts of asarum, 12 parts of Chinese yam, 6 parts of immature bitter orange, 6 parts of
dried orange peel and 9 parts of wrinkled gianthyssop herb.

3. The prescription according to claim 2, wherein the Chinese medicinal raw materials comprise the following Chinese medicinal materials in parts by weight:

9 parts of ephedra, 6 parts of honey-fried licorice root, 9 parts of almond, 15-30 parts of gypsum, 9 parts of cassia twig, 9 parts of rhizoma alismatis, 9 parts of grifola, 9
parts of bighead atractylodes rhizome, 15 parts of poria cocos, 16 parts of radix bupleuri, 6 parts of scutellaria baicalensis, 9 parts of ginger processed pinellia tuber, 9
parts of ginger, 9 parts of aster, 9 parts of os farae, 9 parts of blackberry lily, 6 parts of asarum, 12 parts of Chinese yam, 6 parts of immature bitter orange, 6 parts of
dried orange peel and 9 parts of wrinkled gianthyssop herb.

4. The formulation of any one of claims 1 to 3, in the form of a decoction.

5. A process for the preparation of a formulation as claimed in any one of claims 1 to 4, wherein the raw materials are decocted with water, wherein gypsum is rst
decocted and the other ingredients are then added and decocted.

6. Use of a formulation according to any one of claims 1 to 4 for the manufacture of a medicament having lung clearing and detoxifying effects.

7. Use of a formulation according to any one of claims 1 to 4 in the manufacture of a medicament for the treatment of pulmonary in ammatory diseases.

8. The use of claim 7, wherein the pneumonia is caused by a viral infection.

9. The use according to claim 8, wherein said viruses include, but are not limited to, novel coronavirus 2019-nCoV, respiratory syndrome coronavirus, and respiratory
syncytial virus.

https://patents.google.com/patent/CN110870402A/en?oq=CN110870402 1/7
4/6/2020 CN110870402A - Prescription for treating pneumonia infected by novel coronavirus and application thereof - Google Patents
Description

Prescription for treating pneumonia infected by novel coronavirus and application thereof

Technical Field

The invention relates to a traditional Chinese medicine composition, in particular to a prescription for treating pneumonia infected by novel coronavirus.

Background

2019A novel coronavirus, temporarily named 2019-nCoV coronavirus, is a new strain of coronavirus found in human in 2019. The symptoms of the virus are fever,
hypodynamia, dry cough and gradual dyspnea, and severe patients show acute respiratory distress syndrome, septic shock, metabolic acidosis and blood coagulation
dysfunction which are di cult to correct. The virus is con rmed to have a phenomenon of human transmission, the latent period is infectious, and no speci c treatment
method is provided for the diseases caused by the infectious latent period.

Disclosure of Invention

In order to solve the problems in the prior art, the invention aims to provide a prescription (lung-clearing and toxin-expelling decoction) for treating pneumonia infected by
novel coronavirus and application thereof.

In order to realize the purpose of the invention, the technical scheme of the invention is as follows:

in a rst aspect, the invention provides a prescription for treating pneumonia infected by a novel coronavirus, which comprises the following Chinese medicinal materials
in parts by weight:

8-10 parts of ephedra, 5-8 parts of honey-fried licorice root, 8-10 parts of almond, 15-30 parts of gypsum, 8-10 parts of cassia twig, 8-10 parts of rhizoma alismatis, 8-10
parts of polyporus umbellatus, 8-10 parts of bighead atractylodes rhizome, 15 parts of poria cocos, 15-18 parts of radix bupleuri, 5-8 parts of scutellaria baicalensis, 8-10
parts of ginger processed pinellia tuber, 8-10 parts of ginger, 8-10 parts of aster, 8-10 parts of os farfarae, 8-10 parts of blackberry lily, 5-8 parts of asarum, 10-14 parts
of Chinese yam, 5-8 parts of immature bitter orange, 5-8 parts of dried orange peel and 8-10 parts of wrinkled gianthys.

Preferably, the raw materials of the prescription comprise the following traditional Chinese medicine materials in parts by weight: 9 parts of ephedra, 6 parts of honey-
fried licorice root, 9 parts of almond, 15-30 parts of gypsum, 9 parts of cassia twig, 9 parts of rhizoma alismatis, 9 parts of grifola, 9 parts of bighead atractylodes
rhizome, 15 parts of poria cocos, 16 parts of radix bupleuri, 6 parts of scutellaria baicalensis, 9 parts of ginger processed pinellia tuber, 9 parts of ginger, 9 parts of aster,
9 parts of os farae, 9 parts of blackberry lily, 6 parts of asarum, 12 parts of Chinese yam, 6 parts of immature bitter orange, 6 parts of dried orange peel and 9 parts of
wrinkled gianthyssop herb.

The prescription of the invention refers to the Shang Zhong Jing (treatise on exogenous febrile diseases) of the classic Han Dynasty of traditional Chinese medicine, and
is prepared from ephedra, almond, licorice and gypsum decoction (short for Ma xing Shi Gao decoction, Shang Han Lun 63), Xiao Chaihu decoction (Shang Han Lun 96),
Wu Ling san (Shang Han Lun 71) and blackberry lily and ephedra decoction (Jinkui Yao, lung atrophy, lung carbuncle and cough upper qi syndrome treatment seventh) by
reducing and cutting. The Chinese yam, the immature bitter orange, the dried orange peel and the wrinkled giant hyssop in the prescription are added and subtracted
aiming at the clinical symptoms of the pneumonia infected by the novel coronavirus.

Wherein the Maxingshigan decoction has the effects of ventilating lung and expelling pathogenic factors; the ve-poria cocos disperses dampness-resolving and turbid-
dispelling herbs, promotes the three-warmer and removes dampness from urine, so that the dampness is removed from pores and urine; minor bupleurum soup carding
minor yang machine; the blackberry lily and ephedra decoction has the effects of relieving exterior syndrome, resolving uid retention, depressing qi and relieving cough;
the wrinkled gianthyssop herb, the immature bitter orange and the dried orange peel regulate qi activity of spleen and stomach, and move qi and dissolve turbidity with
fragrance, so that turbid qi in chest and abdomen is removed and breath is smooth; in addition, yam can tonify spleen and kidney, and strengthen healthy qi. The whole
formula has the effects of clearing damp and dissolving turbidity, clearing lung and expelling pathogenic factors and harmonizing qi activity.

Further preferably, the traditional Chinese medicine raw materials of the prescription consist of the following traditional Chinese medicine materials in parts by weight:

9 parts of ephedra, 6 parts of honey-fried licorice root, 9 parts of almond, 15-30 parts of gypsum, 9 parts of cassia twig, 9 parts of rhizoma alismatis, 9 parts of grifola, 9
parts of bighead atractylodes rhizome, 15 parts of poria cocos, 16 parts of radix bupleuri, 6 parts of scutellaria baicalensis, 9 parts of ginger processed pinellia tuber, 9
parts of ginger, 9 parts of aster, 9 parts of os farae, 9 parts of blackberry lily, 6 parts of asarum, 12 parts of Chinese yam, 6 parts of immature bitter orange, 6 parts of
dried orange peel and 9 parts of wrinkled gianthyssop herb.

Wherein the dosage of the gypsum is adjusted according to whether the patient has fever or not, if the patient does not have fever, the dosage of the gypsum is small, and
if the patient has fever or high fever, the dosage of the gypsum is increased.

Furthermore, the formulation is a decoction.

In a second aspect, the invention provides a process for the preparation of said formulation: decocting the above materials with water, wherein Gypsum Fibrosum is
decocted rst, and then other Chinese medicinal materials (decoction pieces of Chinese medicinal materials) are added and decocted.

In a third aspect, the invention provides application of the prescription (lung-clearing and toxin-expelling decoction) in preparation of a medicine with a lung-clearing and
toxin-expelling e cacy.

And the application of the prescription (lung-heat clearing and toxin expelling decoction) in preparing the medicine for treating the pneumonia diseases.

In particular, the pneumonia is pneumonia caused by a viral infection.

The viruses include, but are not limited to, novel coronavirus 2019-nCoV, respiratory syndrome coronavirus, and respiratory syncytial virus.

Objective experiments prove that the prescription disclosed by the invention has a good treatment effect on pneumonia caused by the infection of the novel coronavirus
2019-nCoV.

As a recommendation, the use method of the prescription is as follows: decoct the drugs with water, take them one dose a day, twice in the morning and at night (forty
minutes after meal), and warm. If the condition is met, half bowl of rice soup is taken after each dose of the medicine, and more than one bowl of rice soup can be taken
for patients with dry tongue and uid de ciency. Three treatment courses are provided. The patients are advised to take the medicine for a treatment course according to
the original prescription, and the patients take the medicine for a second treatment course if the symptoms are good and the patients are not cured. If the patient has

https://patents.google.com/patent/CN110870402A/en?oq=CN110870402 2/7
4/6/2020 CN110870402A - Prescription for treating pneumonia infected by novel coronavirus and application thereof - Google Patents
special conditions or other basic diseases, the prescription can be modi ed according to the actual conditions in the second treatment course, and the medicine is
stopped when the symptoms disappear.

In addition, if constipation occurs before taking the formula, Fangfeng Tongsheng Wan should be added, and the pill should be stopped after defecation is smooth.

The raw materials or reagents involved in the invention are all common commercial products, and the operations involved are all routine operations in the eld unless
otherwise speci ed.

The above-described preferred conditions may be combined with each other to obtain a speci c embodiment, in accordance with common knowledge in the art.

The invention has the bene cial effects that:

the invention combines epidemic disease symptom expression of the novel coronavirus pneumonia, and considers that the pneumonia infected by the novel coronavirus
(2019-nCoV) belongs to the eld of cold plague in the traditional Chinese medicine, and dampness pathogen is exuberant. The primary location of the disease is in the
lung, and the secondary location of the disease is in the exterior, defense, spleen and stomach; the main diseases are caused by the intermingled pathogenic factors of
dryness and damp-cold. The main pathogenesis is the damp-cold of epidemic toxin and the accumulation of latent dryness, which causes the obstruction of qi
movement and the abnormal ascending and descending.

The invention provides the prescription, and various traditional Chinese medicines are optimized and fused to be applied together. The curative effect is exact according
to the current curing conditions of patients with con rmed diagnosis at different ages. Relevant clinical observations studies are ongoing.

The prescription (lung-clearing and toxin-expelling decoction) provided by the invention is used by the emergency scienti c research special item of the State
administration of traditional Chinese medicine, namely 'effective prescription clinical screening research on preventing and treating novel coronavirus infection in
traditional Chinese medicine', clinical observation work is carried out by combining clinical treatment at present, and related research is continuously promoted. The
prescription is suitable for light, common and heavy patients, can be reasonably used by combining the actual conditions of the patients in the treatment of the critically
ill patients, and has good social bene ts.

Detailed Description

Preferred embodiments of the present invention will be described in detail with reference to the following examples. It is to be understood that the following examples
are given for illustrative purposes only and are not intended to limit the scope of the present invention. Various modi cations and alterations of this invention will become
apparent to those skilled in the art without departing from the spirit and scope of this invention.

The experimental procedures used in the following examples are all conventional procedures unless otherwise speci ed.

Materials, reagents and the like used in the following examples are commercially available unless otherwise speci ed.

Example 1

This example is used to illustrate the preparation method of the formulation (lung-heat clearing and toxin expelling decoction) of the present invention.

Firstly, raw materials (in parts by weight):

9 parts of ephedra, 6 parts of honey-fried licorice root, 9 parts of almond, 15-30 parts of gypsum, 9 parts of cassia twig, 9 parts of rhizoma alismatis, 9 parts of grifola, 9
parts of bighead atractylodes rhizome, 15 parts of poria cocos, 16 parts of radix bupleuri, 6 parts of scutellaria baicalensis, 9 parts of ginger processed pinellia tuber, 9
parts of ginger, 9 parts of aster, 9 parts of os farae, 9 parts of blackberry lily, 6 parts of asarum, 12 parts of Chinese yam, 6 parts of immature bitter orange, 6 parts of
dried orange peel and 9 parts of wrinkled gianthyssop herb.

Wherein the dosage of the gypsum is adjusted according to whether the patient has fever or not within the dosage range, if the patient does not have fever, the dosage of
the gypsum is small, and if the patient has fever or high fever, the dosage of the gypsum is large.

Second, the preparation method

Weighing the raw materials (Chinese herbal pieces) according to the weight ratio, putting the gypsum into water for decoction, and putting other raw materials (Chinese
herbal pieces) into the water for decoction.

After the decoction is nished, the prescription (lung clearing and toxin expelling decoction) of the invention is obtained.

Experimental example 1

The prescription (lung-clearing and toxin-expelling decoction) prepared in example 1 was administered to the con rmed cases of pneumonia infected with the novel
coronavirus.

Decoct the drugs with water, take them one dose a day, twice in the morning and at night (forty minutes after meal), and warm. If the condition is met, half bowl of rice
soup is taken after each dose of the medicine, and more than one bowl of rice soup can be taken for patients with dry tongue and uid de ciency. Three treatment
courses are provided.

By 2 months and 5 days, the prescription is used in 246 novel pneumonia con rmed cases infected by coronavirus in 37 hospitals in 36 cities of four provinces, and
comprehensive observation is carried out on symptoms of hypodynamia, fever, cough, pharyngalgia, anorexia, imaging and the like, and data show that:

234 patients are effective after taking the medicine, and the total effective rate is about 95.12 percent. Wherein, after 81 patients take the medicine, the symptoms are
stable and not aggravated, and account for about 32.93 percent of the total observed cases; 119 patients had improved symptoms, accounting for approximately 48.37%
of the total observed cases; symptoms of 24 patients disappeared, accounting for about 9.76% of total observed cases; 10 patients were released from quarantine or
discharge and accounted for approximately 4.07% of the total observed cases.

There were 12 patients (4.88%) whose disease continued to progress.

Example 2

This example differs from example 1 in that:

https://patents.google.com/patent/CN110870402A/en?oq=CN110870402 3/7
4/6/2020 CN110870402A - Prescription for treating pneumonia infected by novel coronavirus and application thereof - Google Patents
raw materials (in parts by weight):

8 parts of ephedra, 7 parts of honey-fried licorice root, 10 parts of almond, 15-30 parts of gypsum, 8 parts of cassia twig, 10 parts of rhizoma alismatis, 10 parts of
grifola, 8 parts of bighead atractylodes rhizome, 14 parts of poria cocos, 15 parts of radix bupleuri, 7 parts of scutellaria baicalensis, 10 parts of ginger processed pinellia
tuber, 8 parts of ginger, 10 parts of aster, 8 parts of os farae, 10 parts of blackberry lily, 5 parts of asarum, 13 parts of Chinese yam, 5 parts of immature bitter orange, 7
parts of dried orange peel and 10 parts of wrinkled gianthyssop herb.

Example 3

This example differs from example 1 in that:

raw materials (in parts by weight):

10 parts of ephedra, 6 parts of honey-fried licorice root, 8 parts of almond, 15-30 parts of gypsum, 10 parts of cassia twig, 8 parts of rhizoma alismatis, 8 parts of grifola,
10 parts of bighead atractylodes rhizome, 15 parts of poria cocos, 16 parts of radix bupleuri, 6 parts of scutellaria baicalensis, 9 parts of ginger processed pinellia tuber, 9
parts of ginger, 8 parts of aster, 9 parts of os farae, 10 parts of blackberry lily, 6 parts of asarum, 12 parts of Chinese yam, 6 parts of immature bitter orange, 5 parts of
dried orange peel and 8 parts of wrinkled gianthyssop herb.

Example 4

This example differs from example 1 in that:

raw materials (in parts by weight):

9 parts of ephedra, 6 parts of honey-fried licorice root, 10 parts of almond, 15-30 parts of gypsum, 9 parts of cassia twig, 9 parts of rhizoma alismatis, 10 parts of grifola,
10 parts of bighead atractylodes rhizome, 15 parts of poria cocos, 16 parts of radix bupleuri, 6 parts of scutellaria baicalensis, 9 parts of ginger processed pinellia tuber, 8
parts of ginger, 9 parts of aster, 10 parts of os farae, 9 parts of blackberry lily, 6 parts of asarum, 12 parts of Chinese yam, 5 parts of immature bitter orange, 6 parts of
dried orange peel and 9 parts of wrinkled gianthyssop herb.

Although the invention has been described in detail hereinabove with respect to a general description and speci c embodiments thereof, it will be apparent to those
skilled in the art that modi cations or improvements may be made thereto based on the invention. Accordingly, such modi cations and improvements are intended to be
within the scope of the invention as claimed.

Similar Documents

Publication Publication Date Title

CN102614440B 2014-08-27 Multi-herb antibacterial liquid

CN102755594B 2014-03-12 Traditional Chinese medicine composition for treating acute and chronic hepatitis B and preparation method thereof

CN101130030B 2010-11-17 Medicine composition for treating nephropathy and uses of the same

JP2004161732A 2004-06-10 Natural medicine preparation for treatment of hiv/aids patient

CN101199683B 2010-09-15 Chinese medicine for treating skin disease and preparing method thereof

CN103520395B 2015-04-08 Traditional Chinese medicine composition for treating lung cancer

CN103768308B 2016-05-04 A kind of pharmaceutical composition that is used for the treatment of the infection of the upper respiratory tract and preparation
method thereof

CN1814251A 2006-08-09 Chinese medicine preparation for treating male sterility

CN101461911B 2011-11-02 Chinese medicine oral capsule for treating gout

CN102512611B 2013-05-22 Traditional Chinese medicine for treating recurrent oral ulcer and preparation method

CN103394070A 2013-11-20 Chinese medicine preparation for treating in uenza

CN102488879B 2014-02-05 Medicinal composition for treating rheumatism

CN101143176A 2008-03-19 Traditional Chinese medicine for treating lung cancer

CN104042983A 2014-09-17 Traditional Chinese medicine for treating infantile diarrhea

CN1879868A 2006-12-20 Medicine for treating dysmenorrhea and its preparing method

CN103417946A 2013-12-04 Drug for treatment of urinary calculus

CN103690803B 2016-02-24 A kind of Chinese medicine preparation for the treatment of anaphylactoid purpura

CN103977314A 2014-08-13 Medicinal composition for treating respiratory diseases as well as preparation method and application of medicinal composition

CN103142860A 2013-06-12 Miao medicament for treating pulmonary tuberculosis

https://patents.google.com/patent/CN110870402A/en?oq=CN110870402 4/7
4/6/2020 CN110870402A - Prescription for treating pneumonia infected by novel coronavirus and application thereof - Google Patents
CN101439164A 2009-05-27 Method for preparing Chinese medicine for treating sthenia re type aphtha

CN101549113A 2009-10-07 Traditional Chinese medicine composition for treating urinary system stones and preparation method thereof

CN103386022A 2013-11-13 Chinese medicine composition for treating tuberculous pleurisy

CN103301326B 2014-09-03 Medicament for treating rheumatism, rheumatoid and pain or rheumatism in lower extremities and waist

CN100393338C 2008-06-11 Ointment for treating rhinitis and preparing method

CN101653529A 2010-02-24 Medicine for treating allergic rhinitis

Priority And Related Applications

Priority Applications (1)

Application Priority date Filing date Title

CN202010081961.5A 2020-02-06 2020-02-06 Prescription for treating pneumonia infected by novel coronavirus and application thereof

Applications Claiming Priority (1)

Application Filing date Title

CN202010081961.5A 2020-02-06 Prescription for treating pneumonia infected by novel coronavirus and application thereof

Legal Events

Date Code Title Description

2020-03-06 PB01 Publication

Concepts

machine-extracted Download Filter table

Name Image Sections Count Query match

Alphacoronavirus title,claims,abstract,description 20 0

Pneumonia title,claims,abstract,description 19 0

drug claims,abstract,description 26 0

drugs claims,abstract,description 23 0

Zingiber o cinale claims,abstract,description 22 0

Ephedra claims,abstract,description 14 0

raw materials claims,abstract,description 14 0

Belamcanda claims,abstract,description 13 0

Citrus aurantium claims,abstract,description 13 0

Citrus aurantium claims,abstract,description 13 0

bitter orange claims,abstract,description 13 0

Amygdalus communis claims,abstract,description 12 0

Amygdalus communis claims,abstract,description 12 0

Dioscorea batatas claims,abstract,description 12 0

Dioscorea esculenta claims,abstract,description 12 0

Dioscorea oppositifolia claims,abstract,description 12 0

Dioscorea oppositifolia claims,abstract,description 12 0

Glycyrrhiza glabra claims,abstract,description 12 0

https://patents.google.com/patent/CN110870402A/en?oq=CN110870402 5/7
4/6/2020 CN110870402A - Prescription for treating pneumonia infected by novel coronavirus and application thereof - Google Patents

Glycyrrhiza glabra claims,abstract,description 12 0

licorice root claims,abstract,description 12 0

Agastache urticifolia claims,abstract,description 11 0

Atractylodes claims,abstract,description 11 0

Cinnamomum aromaticum claims,abstract,description 11 0

Cinnamomum aromaticum claims,abstract,description 11 0

Hedysarum boreale claims,abstract,description 11 0

Hedysarum occidentale claims,abstract,description 11 0

Pinellia claims,abstract,description 11 0

Poria cocos claims,abstract,description 11 0

Poria cocos claims,abstract,description 11 0

Scutellaria baicalensis claims,abstract,description 11 0

Scutellaria baicalensis claims,abstract,description 11 0

glycyrrhiza glabra rhizome/root claims,abstract,description 11 0

materials claims,abstract,description 11 0

effects claims,abstract,description 10 0

mixtures claims,abstract,description 9 0

Zingiber o cinale claims,abstract 8 0

Agastache urticifolia claims,abstract 3 0

diseases claims,description 8 0

formulation claims,description 7 0

Viruses claims,description 4 0

syndrome claims,description 3 0

Polyporus umbellatus claims,description 2 0

Polyporus umbellatus claims,description 2 0

Respiratory syncytial virus claims,description 2 0

Viral infection claims,description 2 0

Virus Diseases claims,description 2 0

methods claims,description 2 0

respiratory claims,description 2 0

viral reproduction claims,description 2 0

manufacturing process claims 2 0

in ammatory claims 1 0

ingredients claims 1 0

pulmonary claims 1 0

Infections abstract,description 2 0

Show all concepts from the description section

https://patents.google.com/patent/CN110870402A/en?oq=CN110870402 6/7
4/6/2020 CN110870402A - Prescription for treating pneumonia infected by novel coronavirus and application thereof - Google Patents
About Send Feedback Public Datasets Terms Privacy Policy

https://patents.google.com/patent/CN110870402A/en?oq=CN110870402 7/7